Meditrial published a blog post introducing a clearer framework for highly innovative medical devices addressing serious clinical needs at the MDCG 2025-9 conference.
Published
Signal category
Research & Knowledge
Quote
“#MDCG 2025-9 introduces a clearer #framework for highly innovative medical devices addressing serious clinical needs”
— Meditrial team
Company
Meditrial
CLINICAL TRIALS. FROM START TO FINISH.
- Industry
- Hospitals and Health Care
- Location
- NEW YORK, US
- Company size
- 103 employees
At Meditrial CRO, we empower medical innovators with end-to-end clinical, regulatory, and digital solutions to bring life-changing therapies to market. With a proven track record of success, we navigate complex regulatory landscapes, accelerate clinical trial execution, and provide cutting-edge digital technology to guarantee success. 🌍 Offices: Zürich | Berlin | Rome | London | New York 📍 Learn more: meditrial.net
Founded 2008